Young-Hwan Jung

Young-Hwan Jung is an Assistant Professor in the Department of Neurobiology at the University of Texas Medical Branch at Galveston, with a secondary appointment at the Sealy Institute for Drug Discovery. He leads research in chemical biology and therapeutics, focusing on innovative drug development for catastrophic diseases.

Education:

• PhD in Life Sciences, Gwangju Institute of Science & Technology, South Korea
• BS in Biochemical Engineering, Dongguk University, South Korea

Dr. Jung's research spans targeted protein degradation (TPD), epigenetic modifier development, and bioavailable small molecule design. His lab integrates medicinal chemistry, chemical biology, and computational approaches to combat pain, neurodegeneration, cancer, and infections.

His publications (15 most recent) reveal expertise in P2Y receptor antagonists, PROTAC technology, and multivalent epigenetic drugs. Key subfields include cytochrome P450 inhibition, nucleoside analogs, and glycoconjugate delivery systems.

Jung Lab actively recruits PostDocs and PhD students in medicinal chemistry or chemical biology. The lab team includes postdoctoral fellows Sungmin Yoon and Ga-Ram Kim, with recent collaborations noted during visits to the National Institutes of Health.